| Group I Fosfomycin (N = 38) | Group II Nitrofurantoin (n = 37) | X2 | p value |
Subjective improvement 5 days post treatment | 38/38 (100%) | 32/37 (86.49%) | 11.390 | 0.030* |
Second urinalysis 7 days after treatment | Pus cells 0 - 10/HPF | Pus cells 15-20/HPF | 2.334 | 0.002* |
Compliance of patients | 38/38(100%) | 34/37 (91.89%) | 2.118 | 0.001* |
Cost of therapy | 45 LE | 36 LE | 2.578 | 0.342 |
Side effects of drugs | 7/38 patients (18.42%) | 13/37 patients (35.14%) | 1.209 | 0.003 |
Resistance | 1/38 case (2.63%) One case had 10 pus cells/HPF in second urine analysis due to resistance to Fosfomycin | 8/37 cases (21.62%) | 7.342 | 0.001* |
Cure rate | 97.37% | 78.38% | 2.007 | 0.002* |